Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Diabetic Patients ◽

Converting Enzyme ◽

Mortality And Morbidity

Effects of a New Angiotensin-Converting Enzyme Inhibitor (Idrapril) in Rats with Left Ventricular Dysfunction After Myocardial Infarction

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199603000-00006 ◽

1996 ◽

Vol 27 (3) ◽

pp. 347-354 ◽

Cited By ~ 6

Author(s):

Gordana Jeremic ◽

Serge Masson ◽

Giuseppina Luvarà ◽

Stefano Porzio ◽

Costanza Lagrasta ◽

...

Keyword(s):

Myocardial Infarction ◽

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Converting Enzyme ◽

Beneficial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling in patients with large acute myocardial infarction: the delapril remodeling after acute myocardial infarction (DRAMI) trial

American Heart Journal ◽

10.1016/s0002-8703(02)94777-0 ◽

2003 ◽

Vol 146 (1) ◽

pp. 133A-140A ◽

Cited By ~ 4

Author(s):

Roberto Latini ◽

Lidia Staszewsky ◽

Aldo P Maggioni ◽

Paolo Marino ◽

Francisco Hernandez-Bernal ◽

...

Keyword(s):

Myocardial Infarction ◽

Ventricular Remodeling ◽

Enzyme Inhibitor ◽

Left Ventricular Remodeling ◽

Left Ventricular ◽

Converting Enzyme ◽

Beneficial Effects

Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction

American Heart Journal ◽

10.1053/hj.1998.v136.89405 ◽

1998 ◽

Vol 136 (2) ◽

pp. 269-275 ◽

Cited By ~ 30

Author(s):

Robert E. Foster ◽

David B. Johnson ◽

Francesco Barilla ◽

Gerald G. Blackwell ◽

Roger Orr ◽

...

Keyword(s):

Myocardial Infarction ◽

Left Ventricular Mass ◽

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Converting Enzyme ◽

Angiotensin-Converting Enzyme Inhibitor Therapy Affects Left Ventricular Mass in Patients With Ejection Fraction >40% After Acute Myocardial Infarction

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(96)00451-2 ◽

1997 ◽

Vol 29 (1) ◽

pp. 49-54 ◽

Cited By ~ 30

Author(s):

David B. Johnson ◽

Robert E. Foster ◽

Francesco Barilla ◽

Gerald G. Blackwell ◽

Maryann Roney ◽

...

Keyword(s):

Myocardial Infarction ◽

Ejection Fraction ◽

Left Ventricular Mass ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Converting Enzyme ◽

A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction

New England Journal of Medicine ◽

10.1056/nejm199512213332503 ◽

1995 ◽

Vol 333 (25) ◽

pp. 1670-1676 ◽

Cited By ~ 1115

Author(s):

Lars Køber ◽

Christian Torp-Pedersen ◽

Jan E. Carlsen ◽

Henning Bagger ◽

Per Eliasen ◽

...

Keyword(s):

Myocardial Infarction ◽

Clinical Trial ◽

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Converting Enzyme ◽

AT1-Receptorblocker Versus Angiotensin Converting Enzyme Inhibitor in Acute Myocardial Infarction? Role of Dosage and Bradykinin on Remodeling, Hemodynamics and Mortality in the Rat Model

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(97)85064-4 ◽

1998 ◽

Vol 31 (2) ◽

pp. 311A

Author(s):

P Gaudron

Keyword(s):

Myocardial Infarction ◽

Rat Model ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Lesser Response to Angiotensin-Converting–Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular Dysfunction

New England Journal of Medicine ◽

10.1056/nejm200105033441802 ◽

2001 ◽

Vol 344 (18) ◽

pp. 1351-1357 ◽

Cited By ~ 387

Author(s):

Derek V. Exner ◽

Daniel L. Dries ◽

Michael J. Domanski ◽

Jay N. Cohn

Keyword(s):

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor ◽

White Patients

Early prevention of left ventricular dysfunction after acute myocardial infarction (AMI) with angiotensin converting enzyme (ACE) inhibitors: A randomized control trial

Journal of Clinical Epidemiology ◽

10.1016/0895-4356(96)89196-7 ◽

1996 ◽

Vol 49 ◽

pp. S12

Author(s):

V.L. Gupta ◽

A.K. Mehra ◽

H.R. Kulkarni

Keyword(s):

Myocardial Infarction ◽

Ace Inhibitors ◽

Randomized Control Trial ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Converting Enzyme ◽

Early Prevention ◽

Randomized Control

Long-term combined therapy with losartan and an angiotensin-converting enzyme inhibitor improves functional capacity in patients with left ventricular dysfunction

Acta Cardiologica ◽

10.2143/ac.60.4.2004985 ◽

2005 ◽

Vol 60 (4) ◽

pp. 373-377 ◽

Cited By ~ 6

Author(s):

Sennur Unal DAYI ◽

Tamer AKBULUT ◽

Haldun AKGOZ ◽

Sait TERZI ◽

Nurten SAYAR ◽

...

Keyword(s):

Functional Capacity ◽

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Combined Therapy ◽

Left Ventricular ◽

Converting Enzyme

Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study

American Heart Journal ◽

10.1016/j.ahj.2004.03.035 ◽

2004 ◽

Vol 148 (2) ◽

pp. 292-299 ◽

Cited By ~ 7

Author(s):

Kenji Ueshima ◽

Kennichi Fukami ◽

Katsuhiko Hiramori ◽

Saichi Hosoda ◽

Hiroshi Kishida ◽

...

Keyword(s):

Myocardial Infarction ◽

Secondary Prevention ◽

Japanese Population ◽

Enzyme Inhibitor ◽

Final Report ◽

Converting Enzyme ◽